4//SEC Filing
Hunter Robyn 4
Accession 0001104659-22-053623
CIK 0001429260other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 4:25 PM ET
Size
6.0 KB
Accession
0001104659-22-053623
Insider Transaction Report
Form 4
Hunter Robyn
Chief Financial Officer
Transactions
- Sale
Common Stock, par value $0.001
2021-09-21$3.13/sh−28,292$88,554→ 163,877 total
Footnotes (3)
- [F1]In connection with the vesting of 62,500 shares on September 20, 2021, a total of 28,292 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies.
- [F2]Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on September 21, 2021, was $3.11 to $3.14. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]Of the 163,877 shares, 34,208 shares are restricted stock units.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001713932
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 4:25 PM ET
- Size
- 6.0 KB